ArticleJournal of clinical immunology2025

Identification of Potential Therapeutic Agents for Type I Interferonopathy Using iPSC-Based Disease Modeling.

Bunki Natsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.